PE: How do global pharma growth strategies differ from domestic strategies? Ackerman: There are two different models for ...

Amanda Murphy, Senior Director at GlobalData, discusses how real-time intelligence can turns regulatory events into opportunities.

An advocate for women’s reproductive health, she started one of the world’s smallest pharmaceutical companies to bring an ...

Under the plan, the company will dissolve and its owners, members of the Sackler family, will pay as much as $7 billion of ...

Senior Trump administration health officials have been meeting to discuss how to respond to the year-end ACA subsidy ...

The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...

Artificial intelligence is a wildcard in the selection process, most profoundly in its agentic form. AI agents 2 will help ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Patent reforms could address a problem that’s been driving rising prescription drug costs and create a more competitive ...

In this latest episode of his “Perry and Friends” podcast, Perry Cohen, Pharm.D., a member of the Managed Healthcare ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Pfizer's CEO certainly thinks so. In a TV interview, Bourla said: "Pfizer, when it plays, plays big. And we will -- as we did in COVID, as we did with Lipitor, as we did with ... Viagra, as we did ...